Tepotinib (Tepmetko)

tepotinib · Merck KGaA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tepotinib (Tepmetko), covering 2023-06-09 to 2023-06-09. Get the full timeline:

Most recent: Clinical Trial Update: Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION) [Phase 2]